Cash Flow from Investing Activities: The total change in cash resulting from a company's investments.
AEON Biopharma, Inc. (AEON) had Cash Flow from Investing Activities of $0.00M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-1.16M |
|
-- |
|
-- |
|
$5.92M |
|
$-5.92M |
|
$4.76M |
|
$-1.16M |
|
$-1.16M |
|
$-1.16M |
|
$-1.16M |
|
$-1.16M |
|
$-1.16M |
|
$-5.92M |
|
$-5.90M |
|
50.53M |
|
50.53M |
|
$-0.02 |
|
$-0.02 |
|
| Balance Sheet Financials | |
$3.99M |
|
$0.12M |
|
$1.92M |
|
$5.91M |
|
$7.34M |
|
-- |
|
$13.93M |
|
$21.27M |
|
$-15.36M |
|
$-15.36M |
|
$-15.36M |
|
26.31M |
|
| Cash Flow Statement Financials | |
$-6.33M |
|
|
Cash Flow from Investing Activities |
$0.00M |
$6.76M |
|
$3.01M |
|
$3.43M |
|
$0.42M |
|
$3.59M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.54 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.33M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
7.52% |
|
7.52% |
|
-19.54% |
|
7.52% |
|
$-0.58 |
|
$-0.13 |
|
$-0.13 |
|